VIDEO: Alemtuzumab associated with long-term MS control in TOPAZ studyFebruary 3, 2018Multiple Sclerosis
MS may be a transmissible protein misfolding disorder, study suggestsFebruary 2, 2018Multiple Sclerosis
Rituximab fails to eliminate meningeal inflammation in progressive MSFebruary 1, 2018Multiple Sclerosis
Fingolimod cuts pediatric MS relapse rate more than interferon beta-1aFebruary 1, 2018Multiple Sclerosis
Study finds rising use of newer DMTs in pediatric-onset MSJanuary 31, 2018Multiple SclerosisPediatrics
Rituximab may outperform some other first-line multiple sclerosis treatmentsJanuary 8, 2018Multiple Sclerosis
FDA cites manufacturer of autologous stem cells for regulatory, manufacturing misstepsJanuary 5, 2018Multiple SclerosisStrokeMovement DisordersNeuromuscular Disorders
FDA: Gadolinium retention prompts new GBCA class warning, safety measuresDecember 21, 2017Neuro-oncologyMultiple Sclerosis
